Financhill
Back

MoonLake Immunotherapeutics Stock Predictions

MoonLake Immunotherapeutics Stock Forecast

  • Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 103.5% based on the past 4 years of stock performance.
  • MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is MoonLake Immunotherapeutics Stock Undervalued?
    The current MoonLake Immunotherapeutics [MLTX] share price is $38.93. The Score for MLTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • MLTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will MoonLake Immunotherapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 103.5% based on the past 4 years of stock performance.

MoonLake Immunotherapeutics Stock Rating

Sell
46
MoonLake Immunotherapeutics (MLTX) is a Sell

Is MoonLake Immunotherapeutics overpriced?

  • MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

MoonLake Immunotherapeutics Stock Price History

Is MLTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com

52-Week Data

52-Week High:
58.26
52-Week Low:
31.42

Prediction Charts

Market Cap:
2.5B
Price in USD:
38.93
Volume:
133.2K
Beta:
1.32

Technical Analysis

SMA50:
38.63
SMA100:
41.81
SMA200:
45.84
52-Wk Change:
-2.58%

Stock Predictions

  • Is MoonLake Immunotherapeutics stock public?
    Yes, MoonLake Immunotherapeutics is a publicly traded company.
  • What is the MoonLake Immunotherapeutics stock quote today?
    The MoonLake Immunotherapeutics stock price is 38.93 USD today.
  • How to buy MoonLake Immunotherapeutics stock online?
    You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 41.52 39.27 41.53 38.66
May-7 39.43 37.60 39.43 37.05
May-8 37.70 39.74 40.12 36.75
May-9 39.74 38.47 40.75 38.07
May-12 39.17 40.18 40.86 39.17
May-13 40.58 38.54 41.10 38.31
May-14 38.66 36.99 39.50 36.35
May-15 36.98 37.66 37.76 36.05
May-16 37.65 37.62 38.31 36.69
May-19 38.85 39.20 40.49 37.76
May-20 39.39 40.28 40.43 39.12
May-21 39.83 38.54 40.22 38.47
May-22 38.21 38.51 38.79 37.79
May-23 38.01 38.93 39.08 37.92

MoonLake Immunotherapeutics Earnings

MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

MoonLake Immunotherapeutics Forecast Revenue Growth

MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.26 per share, and a decrease next year of $0.56 per share.

* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.